Compare Danaher Corporation (DHR) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Oatly Group AB - ADR — how do they compare? Danaher Corporation trades at $198.81 (market cap $140.88B), while Oatly Group AB - ADR trades at $9.98 (market cap $304.76M). The key difference: Danaher Corporation is far larger — about 462.3× Oatly Group AB - ADR's market cap, and Danaher Corporation pays a 0.8% dividend while Oatly Group AB - ADR pays none. Which is the better fit depends on your goals.
| DHR | OTLY | |
|---|---|---|
Market Cap | $140.88B | $304.76M |
Sector | Health | Consumer Staples |
52-Week High | $242.05 | $18.54 |
52-Week Low | $161.91 | $8.03 |
Enterprise Value | $153.66B | $802.37M |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
Oatly (OTLY) trades at $10.00, up 1.52% today, showing modest momentum despite ongoing financial challenges. The company maintains a low P/S ratio of 0.35 but suffers from negative profitability metrics including a -17.06% net income margin and -245.57% ROE. Recent Q1 2026 earnings beat expectations with a smaller loss than projected, while technical indicators show mixed signals with an overall bullish bias. Cash flow remains negative but has improved from previous years, with operating cash burn narrowing to -$24 million in 2025.
Oatly faces significant execution risks with persistent losses and high debt levels (66.53% debt-to-asset ratio), though revenue growth continues and cash burn shows improvement. Analyst sentiment is divided with 44% buy ratings but 50% hold recommendations, reflecting cautious optimism about the company's turnaround potential amid competitive pressures in the plant-based beverage market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
